The Kar-Jenner sisters have long faced claims of using Ozempic, a diabetes medicine that gained popularity as a weight-loss aid in 2022. This widespread speculation intensified when Kourtney Kardashian Barker's £2.4 billion supplement brand, Lemme, launched its latest product: an "Ozempic-style" weight-loss supplement named GLP-1 Daily.

Ozempic is a weekly injectable drug containing a synthetic version of the GLP-1 hormone, naturally released by the body after eating. This man-made hormone slows digestion, reduces hunger pangs, and aids in shedding body weight. While Lemme's new GLP-1 Daily directly references the Ozempic hormone and is marketed to "reduce body weight, visceral fat, and hip and waist circumference," it notably lacks the key ingredients found in Ozempic. Instead, Lemme claims its pill aims to naturally increase GLP-1 levels over time using lemon and saffron extracts, promoting itself as a "GLP-1 solution without the side effects" of the injectable drug.

Despite Kourtney not explicitly comparing her product to Ozempic, she promoted an article discussing her desire to be "in on the Ozempic boom." This move, along with the product's marketing, immediately drew sharp criticism from fans and medical professionals alike. Many fans, including those who had previously admired Kourtney's stance on body positivity, accused her of a "facade" and "false marketing," highlighting that no oral supplement can mimic the effects of GLP-1 medications due to rapid enzymatic breakdown.

Doctors and plastic surgeons have also expressed strong skepticism and disapproval. Naveen Cavale, a plastic surgeon, slammed Lemme's GLP-1 Daily as a "cash grab" that is "incredibly misleading." He emphasized that such supplements exploit insecurities in young women by offering quick-fix solutions without scientific backing, potentially exacerbating mental health issues like anxiety, stress, and depression. Cavale stated that unlike Ozempic, which contains semaglutide – a rigorously tested GLP-1 receptor – Lemme's supplement lacks this key ingredient and has little to no clinical evidence to support significant weight loss claims. He reiterated that if it contained GLP-1, it would be classified as a drug, not a supplement, urging individuals to consult medical professionals for effective weight loss solutions.

Furthermore, Lemme's products include a crucial disclaimer: "This product is not intended to diagnose, treat, cure or prevent any disease." This statement indicates that the claims made by the brand have not been evaluated by the Food and Drug Administration (FDA), which is responsible for ensuring the safety and efficacy of drugs and approved supplements.

This isn't the first time Kourtney's Lemme brand, launched in September 2022, has faced controversy. Her "Lemme Purr" vagina gummies, marketed to boost vaginal health and alter taste, were heavily criticized by gynecologist Dr. Jen Gunter. Dr. Gunter famously called out Kourtney, stating, "Anyone who suggests that your vagina isn't fresh or needs an improved taste is a misogynist and awful person." Similarly, the "Lemme Smooth" capsules, launched in June, claimed to reduce cellulite in just 28 days using French Cantaloupe Melon extract. Medical experts, including Naveen Cavale, dismissed these pills as a "fad" lacking scientific backing, reminding consumers that cellulite is a common and natural skin condition.

Kourtney, known as the most health-conscious Kardashian sister, has often spoken about her wellness journey, which she says began after the birth of her eldest son, Mason. Despite her personal commitment to health, the repeated launch of unproven supplements has led to ongoing accusations of exploiting consumer insecurities for profit. A one-time purchase of the GLP-1 Daily pills costs £69, with a monthly subscription priced at £55.23, adding to the criticism regarding their perceived value and efficacy.